RxDoctor Payments DataLook up a doctor →

James Chao, MD

Plastic Surgery · San Diego, CANPI 1093740789

Payments from drug & device makers

$328,040in general payments, 2019–2025

Across 508 payments — averaging $645.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$266K
  • Kerecis Limited$22K
  • W. L. Gore & Associates, Inc.$19K
  • TELA Bio, Inc.$6K
  • AbbVie$3K
  • Acelrx Pharmaceuticals, Inc.$2K
  • plus $10K from 49 others
$26,750in research payments, 2019–2025

Across 3 payments — averaging $8916.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sientra, Inc.$27K

What the payments were for

  • Consulting fees$6,6442%
  • Speaking & faculty fees$259,17079%
  • Travel & lodging$36,81211%
  • Food & beverage$20,1876%
  • Education$4,2001%
  • Gifts$1,0270%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$328,040 in reported general payments places this provider in the 95th percentile of 780 plastic surgery providers in California.

See all plastic surgery providers in California

Medicare billing

Part B allowed, 2024
$28,995
Medicare patients
78
Services billed
254

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen44$294
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen19$223
Cephalexin12$49

Paid to pharmacies, not to this prescriber.

Other plastic surgery in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →